Evidence map›Paper›PMID 36180583›Full record

ReviewMucosal immunology2022

Microbiome-based interventions to modulate gut ecology and the immune system.

Thomas C A Hitch, Lindsay J Hall, Sarah Kate Walsh, Gabriel E Leventhal, Emma Slack, Tomas de Wouters, Jens Walter, Thomas Clavel

Open access · hybridAbstract readReview
In one paragraph

Review in Mucosal immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 135 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
135citing papers in PubMed, 4 pooled it
16.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

135 citing papers in PubMed, 4 syntheses or guidelines pooled it, 205 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

75 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Thomas C A HitchFunctional Microbiome Research Group, Institute of Medical Microbiology, University Hospital of RWTH Aachen, Aachen, Germany.
Lindsay J HallGut Microbes & Health, Quadram Institute Biosciences, Norwich, UK.
Sarah Kate WalshSchool of Food and Nutritional Sciences, University College Cork, Cork, Ireland.
Gabriel E LeventhalPharmaBiome AG, Zürich, Switzerland.
Emma SlackInstitute of Food, Nutrition and Health, Department of Health Sciences and Technology, ETH Zürich, Zürich, Switzerland.
Tomas de WoutersPharmaBiome AG, Zürich, Switzerland.
Jens WalterAPC Microbiome Ireland, School of Microbiology and Department of Medicine, University College Cork, Cork, Ireland.
Thomas ClavelFunctional Microbiome Research Group, Institute of Medical Microbiology, University Hospital of RWTH Aachen, Aachen, Germany. tclavel@ukaachen.de.
APC Microbiome Institute · IERWTH Aachen University · DEETH Zurich · CHLeibniz-Institute for Food Systems Biology at the Technical University of Munich · DE

Funding

Biotechnology and Biological Sciences Research Council BBS/E/F/00044409Biotechnology and Biological Sciences Research Council BBS/E/F/000PR10353Biotechnology and Biological Sciences Research Council BBS/E/F/000PR10356
6 · The paper itself

Abstract

The gut microbiome lies at the intersection between the environment and the host, with the ability to modify host responses to disease-relevant exposures and stimuli. This is evident in how enteric microbes interact with the immune system, e.g., supporting immune maturation in early life, affecting drug efficacy via modulation of immune responses, or influencing development of immune cell populations and their mediators. Many factors modulate gut ecosystem dynamics during daily life and we are just beginning to realise the therapeutic and prophylactic potential of microbiome-based interventions. These approaches vary in application, goal, and mechanisms of action. Some modify the entire community, such as nutritional approaches or faecal microbiota transplantation, while others, such as phage therapy, probiotics, and prebiotics, target specific taxa or strains. In this review, we assessed the experimental evidence for microbiome-based interventions, with a particular focus on their clinical relevance, ecological effects, and modulation of the immune system.

Indexed as

Gastrointestinal MicrobiomeMicrobiotaProbioticsImmune SystemPrebioticsPrebiotics

Identifiers

PMID36180583
PMCPMC9705255
OpenAlexW4298132546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.